Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes
Diabetes, Obesity and Metabolism, 03/05/2009
Monami et al. - The switch from NPH to long-acting analogues as basal insulin replacement in type 1 diabetic patients had a small effect on HbA1c, and also reduced the risk of nocturnal and severe hypoglycaemia.







